ADC Therapeutics S.A.ADCTNYSE
LOADING
|||
Switch Symbol:
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 40.00% |
| Q2 2025 | -38.89% |
| Q1 2025 | -24.14% |
| Q4 2024 | 30.95% |
| Q3 2024 | -10.53% |
| Q2 2024 | 32.14% |
| Q1 2024 | 45.63% |
| Q4 2023 | -77.59% |
| Q3 2023 | 0.00% |
| Q2 2023 | 20.55% |
| Q1 2023 | -143.33% |
| Q4 2022 | 53.85% |
| Q3 2022 | 22.62% |
| Q2 2022 | -281.82% |
| Q1 2022 | 51.11% |
| Q4 2021 | 51.61% |
| Q3 2021 | 2.11% |
| Q2 2021 | -41.79% |
| Q1 2021 | 8.22% |
| Q4 2020 | -151.72% |
| Q3 2020 | 85.57% |
| Q2 2020 | -195.59% |
| Q1 2020 | -41.67% |
| Q4 2019 | -11.63% |
| Q3 2019 | -34.37% |
| Q2 2019 | 39.62% |
| Q1 2019 | 7.02% |
| Q4 2018 | -0.18% |
| Q3 2018 | 0.87% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |